Erdosteine

厄多司坦

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameErdosteine
Drug Alias NameErdosteinumDithiosteineVectrineTussolEdirel +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycoproteins inhibitors
TargetsGlycoproteins
Therapy Area/IndicationsDyspneaCoughPulmonary Disease, Chronic Obstructive +[5] 
Global Approved IndicationsDyspneaCough
Approved Indications in ChinaDyspnea
Original Approved Country/TerritoryItaly
Original Approved Date1993/01/01
Country/TerritoryCzechiaBelgiumBulgaria +[13] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesTanta UniversityZhejiang Kangle Pharmaceutical Co Ltd
Inactive CompaniesEdmond PharmaAdams Respiratory Therapeutics Inc
Active IndicationsDyspneaCoughFatty Liver
Inactive IndicationsPulmonary Disease, Chronic ObstructiveBronchitis, Chronic

Other Information

ATC CodeR05CB15
Related LinksWikipediaDrugBankKEGG